Maple Capital Management Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,643 shares of the medical equipment provider’s stock after acquiring an additional 1,181 shares during the quarter. Intuitive Surgical makes up 1.5% of Maple Capital Management Inc.’s investment portfolio, making the stock its 23rd largest holding. Maple Capital Management Inc.’s holdings in Intuitive Surgical were worth $20,692,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in ISRG. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Analyst Ratings Changes
ISRG has been the subject of a number of analyst reports. Truist Financial boosted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $613.10.
Insider Buying and Selling
In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,077 shares of company stock worth $4,620,025. Corporate insiders own 0.80% of the company’s stock.
Intuitive Surgical Stock Up 1.7 %
ISRG stock opened at $573.15 on Friday. The company has a market cap of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business has a 50-day simple moving average of $569.87 and a 200 day simple moving average of $528.64.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Do S&P 500 Stocks Tell Investors About the Market?
- 5 Best Gold ETFs for March to Curb Recession Fears
- Stock Splits, Do They Really Impact Investors?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.